Trial Profile
Double blind randomized study to evaluate the efficiency of intravenous ferric carboxymaltose in preventing anemia after cardiopulmonary bypass in children with congenital heart disease Doppelblind randomisierte Studie zur Evaluierung der Wirksamkeit der Gabe von Eisen(III)carboxymaltose zur Verhinderung von postoperativer Anämie nach Operation angeborener Herzfehler
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2014
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 24 Oct 2014 New trial record